205 related articles for article (PubMed ID: 15581980)
1. Polymorphisms of interleukin (IL)-1alpha, IL-1beta, IL-6, IL-10, and IL-18 and the risk of ovarian cancer.
Bushley AW; Ferrell R; McDuffie K; Terada KY; Carney ME; Thompson PJ; Wilkens LR; Tung KH; Ness RB; Goodman MT
Gynecol Oncol; 2004 Dec; 95(3):672-9. PubMed ID: 15581980
[TBL] [Abstract][Full Text] [Related]
2. Vitamin D receptor gene polymorphisms and epithelial ovarian cancer risk.
Lurie G; Wilkens LR; Thompson PJ; McDuffie KE; Carney ME; Terada KY; Goodman MT
Cancer Epidemiol Biomarkers Prev; 2007 Dec; 16(12):2566-71. PubMed ID: 18086759
[TBL] [Abstract][Full Text] [Related]
3. An association study of inflammatory cytokine gene polymorphisms in Fabry disease.
Safyan R; Whybra C; Beck M; Elstein D; Altarescu G
Eur Cytokine Netw; 2006 Dec; 17(4):271-5. PubMed ID: 17353161
[TBL] [Abstract][Full Text] [Related]
4. Polymorphisms in BRCA1 and BRCA2 and risk of epithelial ovarian cancer.
Wenham RM; Schildkraut JM; McLean K; Calingaert B; Bentley RC; Marks J; Berchuck A
Clin Cancer Res; 2003 Oct; 9(12):4396-403. PubMed ID: 14555511
[TBL] [Abstract][Full Text] [Related]
5. Genetic variants of interleukin-1RN and interleukin-1beta genes and risk of cervical cancer.
Singh H; Sachan R; Goel H; Mittal B
BJOG; 2008 Apr; 115(5):633-8. PubMed ID: 18333945
[TBL] [Abstract][Full Text] [Related]
6. Polymorphisms in the promoter regions of the matrix metalloproteinases-1, -3, -7, and -9 and the risk of epithelial ovarian cancer in China.
Li Y; Jin X; Kang S; Wang Y; Du H; Zhang J; Guo W; Wang N; Fang S
Gynecol Oncol; 2006 Apr; 101(1):92-6. PubMed ID: 16278009
[TBL] [Abstract][Full Text] [Related]
7. Genetic variation in pro-inflammatory cytokines (interleukin-1beta, interleukin-1alpha and interleukin-6) associated with the aggressive forms, survival, and relapse prediction of breast carcinoma.
Snoussi K; Strosberg AD; Bouaouina N; Ben Ahmed S; Chouchane L
Eur Cytokine Netw; 2005 Dec; 16(4):253-60. PubMed ID: 16464738
[TBL] [Abstract][Full Text] [Related]
8. The steroid 5alpha-reductase type II TA repeat polymorphism is not associated with risk of breast or ovarian cancer in Australian women.
Spurdle AB; Hopper JL; Chen X; Dite GS; McCredie MR; Giles GG; Venter DJ; Southey MC; Purdie DM; Chenevix-Trench G
Cancer Epidemiol Biomarkers Prev; 2001 Dec; 10(12):1287-93. PubMed ID: 11751447
[TBL] [Abstract][Full Text] [Related]
9. Double-strand break repair gene polymorphisms and risk of breast or ovarian cancer.
Webb PM; Hopper JL; Newman B; Chen X; Kelemen L; Giles GG; Southey MC; Chenevix-Trench G; Spurdle AB
Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):319-23. PubMed ID: 15734952
[TBL] [Abstract][Full Text] [Related]
10. Polymorphism of IL-1alpha, IL-1beta and IL-10 in patients with advanced ovarian cancer: results of a prospective study with 147 patients.
Ioana Braicu E; Mustea A; Toliat MR; Pirvulescu C; Könsgen D; Sun P; Nürnberg P; Lichtenegger W; Sehouli J
Gynecol Oncol; 2007 Mar; 104(3):680-5. PubMed ID: 17141301
[TBL] [Abstract][Full Text] [Related]
11. Polymorphisms of the interleukin-1 gene cluster and ovarian cancer.
Hefler LA; Ludwig E; Lebrecht A; Zeillinger R; Tong-Cacsire D; Koelbl H; Leodolter S; Tempfer CB
J Soc Gynecol Investig; 2002; 9(6):386-90. PubMed ID: 12445604
[TBL] [Abstract][Full Text] [Related]
12. Genotypic and functional roles of IL-1B and IL-1RN on the risk of gastroesophageal reflux disease: the presence of IL-1B-511*T/IL-1RN*1 (T1) haplotype may protect against the disease.
Chourasia D; Achyut BR; Tripathi S; Mittal B; Mittal RD; Ghoshal UC
Am J Gastroenterol; 2009 Nov; 104(11):2704-13. PubMed ID: 19603010
[TBL] [Abstract][Full Text] [Related]
13. Interleukin 1alpha, interleukin 1beta and interleukin 1 receptor gene polymorphisms in psoriatic arthritis.
Ravindran JS; Owen P; Lagan A; Lewis J; Korendowych E; Welsh K; McHugh N
Rheumatology (Oxford); 2004 Jan; 43(1):22-6. PubMed ID: 12890860
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-1 receptor antagonist gene polymorphism in epithelial ovarian cancer.
Sehouli J; Mustea A; Koensgen D; Lichtenegger W
Cancer Epidemiol Biomarkers Prev; 2003 Nov; 12(11 Pt 1):1205-8. PubMed ID: 14652282
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-10 G-1082A and C-819T polymorphisms as possible molecular markers of urothelial bladder cancer.
Ahirwar D; Mandhani A; Mittal RD
Arch Med Res; 2009 Feb; 40(2):97-102. PubMed ID: 19237018
[TBL] [Abstract][Full Text] [Related]
16. A study on the association of cytochrome-P450 1A1 polymorphism and breast cancer risk in north Indian women.
Singh V; Rastogi N; Sinha A; Kumar A; Mathur N; Singh MP
Breast Cancer Res Treat; 2007 Jan; 101(1):73-81. PubMed ID: 16807674
[TBL] [Abstract][Full Text] [Related]
17. Association of IL-1B gene polymorphisms with nasopharyngeal carcinoma in a Chinese population.
Zhu Y; Xu Y; Wei Y; Liang W; Liao M; Zhang L
Clin Oncol (R Coll Radiol); 2008 Apr; 20(3):207-11. PubMed ID: 18289837
[TBL] [Abstract][Full Text] [Related]
18. [Association of three single nucleotide polymorphisms of the E-cadherin gene with susceptibility to epithelial ovarian carcinoma].
Liang J; Li Y; Wang N
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Apr; 25(2):183-6. PubMed ID: 18393242
[TBL] [Abstract][Full Text] [Related]
19. Case-control study of ovarian cancer and polymorphisms in genes involved in catecholestrogen formation and metabolism.
Goodman MT; McDuffie K; Kolonel LN; Terada K; Donlon TA; Wilkens LR; Guo C; Le Marchand L
Cancer Epidemiol Biomarkers Prev; 2001 Mar; 10(3):209-16. PubMed ID: 11303589
[TBL] [Abstract][Full Text] [Related]
20. PGR +331 A/G and increased risk of epithelial ovarian cancer.
Risch HA; Bale AE; Beck PA; Zheng W
Cancer Epidemiol Biomarkers Prev; 2006 Sep; 15(9):1738-41. PubMed ID: 16985038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]